There are isolated reports of overdose with fulvestrant in humans. Animal studies suggest that no effects other than those related directly or indirectly to anti-oestrogenic activity were evident with higher doses of fulvestrant. If overdose occurs, symptomatic supportive treatment is recommended.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
